ALK and squamous cell carcinoma: Activating mutations in epidermal growth factor receptor (EGFR) and anaplastic lymphoma kinase (ALK) rearrangement are the major driving force for lung adenocarcinoma while most squamous cell carcinomas display somatic mutation of p534,6–8.